Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...

The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Corporate America is counting the cost of Donald Trump’s trade war, with executives warning of escalating expenditures, gummed-up supply chains and a hit to the world’s largest economy.

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, ...

Wall Street analysts expect Johnson & Johnson (JNJ) to post quarterly earnings of $2.57 per share in its upcoming report, which indicates a year-over-year decline of 5.2%. Revenues are expected to ...

"When people are vomiting up stocks, you gotta be in there cleaning it up," Craig Johnson told Business Insider.

Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.

Johnson & Johnson stock slipped Tuesday, even after the company reported first-quarter earnings that surpassed expectations ...

The US Customs and Border Protection announced a tariff exclusion for some electronics on Friday, only for US Commerce ...